Larry Orecklin, Vice President World Wide Specialist Sales, on the changing customer landscape of apps, devices and data and Microsoft's approach to building...
.Blog
Consolidation, Patent Loses, Weak R&D Productivity Depress ITO Transactions in Life Sciences Segment: Everest Group Annual Report Migrate from Outlook Express to Outlook by Britec
Dallas, Texas (PRWEB) October 22, 2013 ITO transaction activity in the life sciences industry slowed markedly in 2012, falling from 82 deals to 54, due to multiple challenges that included patent losses, middling R&D productivity, and rising consolidation.
Smaller life sciences firms ? those with less than US$.
Growing Your Hosting Business with the Microsoft Cloud Platform
As the shift to the cloud is accelerating and becoming more broadly adopted by businesses globally, Microsoft sees hosting service provider partners as a cor...
.